Intesity Therapeutics Inc (INTS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current INTS market cap is 33.42M. The company's latest EPS is USD -0.8554 and P/E is -2.82.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.49M | -3.35M | -4.74M | -5.07M | -3.57M |
| Net Income | -3.65M | -3.17M | -4.6M | -4.97M | -3.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.68M | -6.22M | -8.01M | -7.63M | -8.32M |
| Net Income | -5.38M | -6.03M | -7.9M | -7.58M | -11.86M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 16.82M | 17.3M | 12.41M | 8.67M | 5.21M |
| Total Liabilities | 905k | 4.13M | 2.69M | 3.33M | 2.43M |
| Total Equity | 15.91M | 13.16M | 9.72M | 5.35M | 2.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.93M | 10.15M | 5.22M | 1.76M | 17.3M |
| Total Liabilities | 1.31M | 1.71M | 3.9M | 6.85M | 4.13M |
| Total Equity | -2.38M | -1.56M | -8.68M | -15.1M | 13.16M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.26M | -7.21M | -4.37M | -8.58M | -12.55M |
| Investing | -8.84M | -6.02M | 3.26M | 3.25M | 6.35M |
| Financing | 20.48M | 20.47M | 8k | 11k | 424k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.42M | -5.37M | -6.83M | -5.48M | -7.21M |
| Investing | 1.7M | 4.57M | N/A | N/A | -6.02M |
| Financing | 3.86M | 6.29M | 2.05M | 2.25M | 20.47M |
| Market Cap | 33.42M |
| Price to Earnings Ratio | -2.82 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.91 |
| Price to Book Ratio | 2.54 |
| Dividend Yield | - |
| Shares Outstanding | 13.87M |
| Average Volume (1 week) | 24.98k |
| Average Volume (1 Month) | 41.59k |
| 52 Week Change | -41.50% |
| 52 Week High | 5.94 |
| 52 Week Low | 1.50 |
| Spread (Intraday) | 2.18 (57.98%) |
| Company Name | Intesity Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
